Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

As the weather begins to get warm, every year, without fail, there is an uptick in canine parvovirus. Canine parvovirus first came into the picture in 1978, when Feline Panleukopenia (a separate virus ...

Altesa BioSciences today announced positive topline results from its Phase 2 placebo-controlled study examining the effects of vapendavir in COPD patients challenged with rhinovirus.  In this study, ...

Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented ...

As China and the United States trade charges of a lab leak, researchers contend in a new paper that the Covid pandemic got ...

The initial spread of the virus that causes COVID-19 might have been accelerated by the wildlife trade, similar to what ...

The US Food and Drug Administration has approved CRISPR gene-edited pigs for human consumption. As MIT Technology Review ...

Studies show how spike protein changes determine the risk of viral outbreaks, offering important insights for the future ...

The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...

Researchers from the University of São Paulo in Brazil have discovered that silver nanoparticles produced by a fungus called ...